Shuxiang Wu

机构：Fujian Medical University

发表论文 15 篇 · 总被引 407 次 · h-index 10

代表论文

AKT activator SC79 protects hepatocytes from TNF-α-mediated apoptosis and alleviates d -Gal/LPS-induced liver injury (2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology · 被引 93)
Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling (2020 · Cancer Letters · 被引 63)
PI3K/AKT inhibitors aggravate death receptor-mediated hepatocyte apoptosis and liver injury (2019 · Toxicology and Applied Pharmacology · 被引 39)
A Novel AKT Activator, SC79, Prevents Acute Hepatic Failure Induced by Fas-Mediated Apoptosis of Hepatocytes (2018 · American Journal Of Pathology · 被引 38)
Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling (2018 · Journal of Virology · 被引 37)
Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation (2018 · The Journal of Immunology · 被引 34)